What are the treatment options for native valve endocarditis caused by Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment of Native Valve Enterococcus faecalis Endocarditis

For native valve Enterococcus faecalis endocarditis, treat with ampicillin 2g IV every 4 hours PLUS ceftriaxone 2g IV every 12 hours for 6 weeks, which is the current guideline-recommended first-line regimen. 1

Primary Treatment Regimen

The ampicillin-ceftriaxone (AC) combination is now the preferred approach over traditional aminoglycoside-containing regimens for several compelling reasons:

  • Reduced nephrotoxicity: The AC regimen eliminates the significant kidney injury risk associated with gentamicin, which occurs in approximately 50% of patients receiving aminoglycoside combinations 2
  • No need for drug level monitoring: Unlike gentamicin, which requires therapeutic drug monitoring
  • Equivalent efficacy: Success rates with AC therapy match those historically achieved with ampicillin-gentamicin regimens 1

Duration of Therapy

Always treat for 6 weeks, regardless of symptom duration. 1 While older guidelines suggested 4 weeks might suffice for uncomplicated native valve cases with symptoms <3 months when using ampicillin-gentamicin, recent evidence shows this is inadequate:

  • Relapse rates are significantly higher with 4-week courses (17% vs 2% with 6 weeks) 3
  • This finding applies to both AC and ampicillin-gentamicin regimens
  • Cirrhotic patients are particularly vulnerable to relapse with shorter courses 3

Alternative Regimens

When Ampicillin Cannot Be Used

If the patient cannot tolerate ampicillin due to allergy or unavailability:

Penicillin G 24 million units/24h IV (continuous or divided every 4-6 hours) PLUS ceftriaxone 2g IV every 12 hours for 6 weeks is a reasonable alternative 4. This penicillin-ceftriaxone combination has demonstrated cure in case reports when ampicillin was not feasible.

For Aminoglycoside-Susceptible Strains (If AC Not Possible)

Ampicillin 2g IV every 4 hours PLUS gentamicin 3 mg/kg/day IV in a single daily dose:

  • Duration: 4-6 weeks depending on symptom duration (4 weeks if symptoms <3 months, 6 weeks if ≥3 months) 1
  • Critical caveat: Recent observational data shows combination gentamicin therapy had lower 30-day mortality (16.4%) compared to monotherapy (38.5%), BUT acute kidney injury occurred in 50% of gentamicin-treated patients 2
  • Avoid gentamicin if creatinine clearance <30 mL/min 1

For β-Lactam Intolerant Patients

Vancomycin 30 mg/kg/day IV in 2 divided doses PLUS gentamicin 3 mg/kg/day IV for 6 weeks 1

Important warning: This combination is inferior to β-lactam-based regimens both in vitro and in animal models, and carries higher risks of nephrotoxicity and ototoxicity 1. Use only when β-lactams are absolutely contraindicated.

Emerging Considerations

Transition to Oral Therapy

After initial IV therapy, transition to oral antibiotics is a reasonable option based on three randomized trials demonstrating non-inferiority of partial oral therapy compared to IV-only treatment 5. This approach can reduce complications from prolonged IV access and volume overload.

Volume Management

The standard AC regimen delivers substantial salt and fluid volume, which is problematic in patients with heart failure—a common comorbidity in endocarditis 6. Consider:

  • Push administration rather than prolonged infusions when feasible
  • Early transition to partial oral therapy to reduce IV fluid burden
  • Close monitoring for hypervolemia, which worsens outcomes

Critical Pitfalls to Avoid

  1. Do not use monotherapy: Observational data shows significantly worse outcomes with single-agent therapy (38.5% vs 16.4% mortality) 2

  2. Do not routinely add aminoglycosides to AC regimens: The 2023 WikiGuidelines explicitly recommend against routine aminoglycoside use due to lack of benefit with demonstrable harm 5

  3. Do not shorten therapy to 4 weeks: Despite older guideline suggestions, the relapse rate is unacceptably high 3

  4. Verify aminoglycoside susceptibility before use: For gentamicin-resistant but streptomycin-susceptible strains, the AC regimen is the appropriate choice 1

  5. Avoid streptomycin if creatinine clearance <50 mL/min 1

Special Populations

For prosthetic valve endocarditis: All regimens require a minimum of 6 weeks, with no option for shorter courses 1

For aminoglycoside-resistant strains: The AC regimen is specifically recommended as it maintains efficacy without aminoglycoside dependence 1

References

Related Questions

Can I use ceftriaxone in a patient with a mild ampicillin allergy for culture‑negative infective endocarditis, and what is the recommended treatment duration for native versus prosthetic valves?
Is a penicillin‑sensitive Enterococcus faecalis susceptible to oxacillin?
What is the recommended treatment dose of Amoxicillin (amoxicillin) for Enterococcus faecalis endocarditis?
In an elderly patient with recent Enterococcus faecalis urinary tract infection, bacteremia, and endocarditis, a 4 mm aortic bioprosthetic valve opacity, now presenting with painful palpable purpura that has progressed to bullae and new transaminitis while on daptomycin, who previously received intravenous ampicillin and ceftriaxone (Rocephin) and has a history of transcatheter aortic valve replacement (TAVR) with pacemaker, atrial fibrillation on apixaban (Eliquis), and daily furosemide with as‑needed potassium supplementation, how should I work up and manage the suspected drug‑induced bullous leukocytoclastic vasculitis versus other vasculitic etiologies from a pharmacy standpoint?
What empiric antibiotic regimen should be used for culture-negative infective endocarditis in a patient with an ampicillin allergy?
In a patient with known atrial fibrillation (AF) and coronary artery bypass graft (CABG) performed two years ago, what is the recommended management?
How should calcific mitral valve leaflets be evaluated and managed?
When does serum prolactin return to normal postpartum?
What could cause a one-week history of cough, chest pain, and intermittent shortness of breath, and do I need urgent medical evaluation?
What is the most likely diagnosis and recommended workup for isolated unilateral hip‑flexor weakness occurring after a recent viral infection?
What is the recommended vitamin D3 supplementation dosage for a healthy adult without a known deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.